Figure 1From: The influence of nevirapine and efavirenz-based anti-retroviral therapy on the pharmacokinetics of lumefantrine and anti-malarial dose recommendation in HIV-malaria co-treatmentLumefantrine concentration time profiles for HIV-malaria-co-infected- patients on antiretroviral drugs and those not yet on antiretroviral drugs.Back to article page
